<Cites Ariazi, E.A.. et al. 2007>

1. Harvell, D. M. E., Spoelstra, N. S., Singh, M., McManaman, J. L., Finlayson, C., Phang, T., et al. (2008). Molecular signatures of neoadjuvant endocrine therapy for breast cancer: Characteristics of response or intrinsic resistance. Breast Cancer Research and Treatment, 112(3), 475-488.

2. Miller, W. R., Bartlett, J., Brodie, A. M. H., Brueggemeier, R. W., Di Salle, E., Lønning, P. E., et al. (2008). Aromatase inhibitors: Are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist, 13(8), 829-837.

<Cites Arnold, D. et al. 2007>

3. Wu, G. S. (2007). Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer and Metastasis Reviews, 26(3-4), 579-585.

<Cites Buranda, T. et al. 2007>

4. Lohse, M. J., Nikolaev, V. O., Hein, P., Hoffmann, C., Vilardaga, J. -., & Bünemann, M. (2008). Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends in Pharmacological Sciences, 29(3), 159-165.

5. Huber, T., Menon, S., & Sakmar, T. P. (2008). Structural basis for ligand binding and specificity in adrenergic receptors: Implications for GPCR-targeted drug discovery. Biochemistry, 47(42), 11013-11023.

<Cites Davis,R., 2007>

6. Niles, W. D., & Coassin, P. J. (2008). Cyclic olefin polymers: Innovative materials for high-density multiwell plates. Assay and Drug Development Technologies, 6(4), 577-590.

<Cites Diamond, S.L. 2007>

7. Kofoed, J., & Reymond, J. -. (2007). Identification of protease substrates by combinatorial profiling on TentaGel beads. Chemical Communications, (43), 4453-4455.

8. Edwards, P. J. (2008). Combinatorial library methodology applied to cancer and protease targets. thiazolidinone derivatives targeting drug-resistant lung cancer cells. Drug Discovery Today, 13(23-24), 1107-1108.

9. Fluxá, V. S., Wahler, D., & Reymond, J. -. (2008). Enzyme assay and activity fingerprinting of hydrolases with the red-chromogenic adrenaline test. Nature Protocols, 3(8), 1270-1277.

10. Kadonosono, T., Kato-Murai, M., & Ueda, M. (2008). Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation. Protein Engineering, Design and Selection, 21(8), 507-513.

11. Andersen, L. M., Wind, T., Hansen, H. D., & Andreasen, P. A. (2008). A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: Changing species specificity by substitution of a single residue. Biochemical Journal, 412(3), 447-457.

12. Schilling, O., & Overall, C. M. (2008). Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nature Biotechnology, 26(6), 685-694.

13. Li, H. -., Hwang, B. -., Laxmikanthan, G., Blaber, S. I., Blaber, M., Golubkov, P. A., et al. (2008). Substrate specificity of human kallikreins 1 and 6 determined by phage display. Protein Science, 17(4), 664-672.

<Cites Don, A. et al 2007>

14. Sankala, H. M., Hait, N. C., Paugh, S. W., Shida, D., Lépine, S., & Elmore, L. W. et al. (2007). Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Research, 67(21), 10466-10474.

15. Schwab, S. R., & Cyster, J. G. (2007). Finding a way out: Lymphocyte egress from lymphoid organs. Nature Immunology, 8(12), 1295-1301. Retrieved February 12, 2008, from Scopus database.

16. Gude, D. R., Alvarez, S. E., Paugh, S. W., Mitra, P., Yu, J., Griffiths, R., et al. (2008). Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. FASEB Journal, 22(8), 2629-2638.

<Cites Feng, B. et al. 2007>

17. Kawamura, A., Hindi, S., Mihai, D. M., James, L., & Aminova, O. (2008). Binding is not enough: Flexibility is needed for photocrosslinking of lck kinase by benzophenone photoligands. Bioorganic and Medicinal Chemistry, 16(19), 8824-8829.

18. Palchaudhuri, R., Nesterenko, V., & Hergenrother, P. J. (2008). The complex role of the triphenylmethyl motif in anticancer compounds. Journal of the American Chemical Society, 130(31), 10274-10281.

19. Nakamura, K., Zawistowski, J. S., Hughes, M. A., Sexton, J. Z., Yeh, L. -., Johnson, G. L., et al. (2008). Homogeneous time-resolved fluorescence resonance energy transfer assay for measurement of Phox/Bem1p (PB1) domain heterodimerization. Journal of Biomolecular Screening, 13(5), 396-405.

20. Cheng, L. S., Amaro, R. E., Xu, D., Li, W. W., Arzberger, P. W., & McCammon, J. A. (2008). Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. Journal of Medicinal Chemistry, 51(13), 3878-3894.

21. Snow, C. D. (2008). Hunting for predictive computational drug-discovery models. Expert Review of Anti-Infective Therapy, 6(3), 291-293.

22. Rishton, G. M. (2008). Molecular diversity in the context of leadlikeness: Compound properties that enable effective biochemical screening. Current Opinion in Chemical Biology, 12(3), 340-351.

23. Peterson, R. T., Nass, R., Boyd, W. A., Freedman, J. H., Dong, K., & Narahashi, T. (2008). Use of non-mammalian alternative models for neurotoxicological study. NeuroToxicology, 29(3), 545-554.

24. Goode, D. R., Totten, R. K., Heeres, J. T., & Hergenrother, P. J. (2008). Identification of promiscuous small molecule activators in high-throughput enzyme activation screens. Journal of Medicinal Chemistry, 51(8), 2346-2349. Matter, A., & Keller, T. H. (2008). Impact of non-profit organizations on drug discovery: Opportunities, gaps, solutions. Drug Discovery Today, 13(7-8), 347-352. Matějíček, P., Cígler, P., Olejniczak, A. B., Andrysiak, A., Wojtczak, B., Procházka, K., et al. (2008). Aggregation behavior of nucleoside-boron cluster conjugates in aqueous solutions. Langmuir, 24(6), 2625-2630.

25. Kolb, P., Huang, D., Dey, F., & Caflisch, A. (2008). Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model. Journal of Medicinal Chemistry, 51(5), 1179-1188.

26. Hsieh, J. -., Wang, X. S., Teotico, D., Golbraikh, A., & Tropsha, A. (2008). Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening. Journal of Computer-Aided Molecular Design, 22(9), 593-609.

27. Giannetti, A. M., Koch, B. D., & Browner, M. F. (2008). Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. Journal of Medicinal Chemistry, 51(3), 574-580.

28. Wells, J. A., & McClendon, C. L. (2007). Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature, 450(7172), 1001-1009.

29. Congdon, E. E., Necula, M., Blackstone, R. D., & Kuret, J. (2007). Potency of a tau fibrillization inhibitor is influenced by its aggregation state. Archives of Biochemistry and Biophysics, 465(1), 127-135.

<Cites Ganesh,T. et al. 2007>

30. Itokawa, H., Morris-Natschke, S. L., Akiyama, T., & Lee, K. -. (2008). Plant-derived natural product research aimed at new drug discovery. Journal of Natural Medicines, 62(3), 263-280.

31. Santhapuram, H. K. R., Datta, A., Hutt, O. E., & Georg, G. I. (2008). N-methylation of the C3′ amide of taxanes: Synthesis of N-methyltaxol C and N-methylpaclitaxel. Journal of Organic Chemistry, 73(12), 4705-4708.

32. Liu, B., Yang, M., Li, R., Ding, Y., Qian, X., Yu, L., et al. (2008). The antitumor effect of novel docetaxel-loaded thermosensitive micelles. European Journal of Pharmaceutics and Biopharmaceutics, 69(2), 527-534.

33. Tietze, L. F., Panknin, O., Krewer, B., Major, F., & Schuberth, I. (2008). Synthesis and biological evaluation of a novel pentagastrin-toxin conjugate designed for a targeted prodrug monotherapy of cancer. International Journal of Molecular Sciences, 9(5), 821-837.

34. Atkinson, J. M., Siller, C. S., & Gill, J. H. (2008). Tumour endoproteases: The cutting edge of cancer drug delivery? British Journal of Pharmacology, 153(7), 1344-1352.

<Cites Gonzalez-Cabrera, P. et al. 2007>

35. Allende, M. L., Zhou, D., Kalkofen, D. N., Benhamed, S., Tuymetova, G., & Borowski, C. et al. (2008). S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB Journal, 22(1), 307-315.

36. Bieberich, E. (2008). Smart drugs for smarter stem cells: Making SENSe (sphingolipid-enhanced neural stem cells) of ceramide. NeuroSignals, 16(2-3), 124-139.

37. Cinamon, G., Zachariah, M. A., Lam, O. M., Foss Jr., F. W., & Cyster, J. G. (2008). Follicular shuttling of marginal zone B cells facilitates antigen transport. Nature Immunology, 9(1), 54-62.

38. Cooke, N., & Zécri, F. (2007). Chapter 16 sphingosine 1-phosphate type 1 receptor modulators: Recent advances and therapeutic potential.

39. Jung, C. G., Kim, H. J., Miron, V. E., Cook, S., Kennedy, T. E., & Foster, C. A. et al. (2007). Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. GLIA, 55(16), 1656-1667.

40. Schwab, S. R., & Cyster, J. G. (2007). Finding a way out: Lymphocyte egress from lymphoid organs. Nature Immunology, 8(12), 1295-1301.

41. Miron, V. E., Schubart, A., & Antel, J. P. (2008). Central nervous system-directed effects of FTY720 (fingolimod). Journal of the Neurological Sciences, 274(1-2), 13-17.

42. Liang, W., Hoang, Q., Clark, R. B., & Fishman, P. H. (2008). Accelerated dephosphorylation of the β2-adrenergic receptor by mutation of the C-terminal lysines: Effects on ubiquitination, intracellular trafficking, and degradation. Biochemistry, 47(45), 11750-11762.

43. Rivera, J., Proia, R. L., & Olivera, A. (2008). The alliance of sphingosine-1-phosphate and its receptors in immunity. Nature Reviews Immunology, 8(10), 753-763.

44. Cahalan, M. D., & Parker, I. (2008). Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs

45. Ryan, J. J., & Spiegel, S. (2008). The role of sphingosine-1-phosphate and its receptors in asthma. Drug News and Perspectives, 21(2), 89-96.

<Cites Hristozov. et al. 2007>

46. Senger, S., & Leach, A. R. (2008). Chapter 11 SAR knowledge bases in drug discovery

<Cites Huryn. et al. 2007>

47. Senger, S., & Leach, A. R. (2008). Chapter 11 SAR knowledge bases in drug discovery

48. Grant, D., Dahl, R., & Cosford, N. D. P. (2008). Rapid multistep synthesis of 1,2,4-oxadiazoles in a single continuous microreactor sequence. Journal of Organic Chemistry, 73(18), 7219-7223.

49. Smith III, A. B., Kim, W. -., & Wuest, W. M. (2008). Ortho-TMS benzaldehyde: An effective linchpin for type II anion relay chemistry (ARC). Angewandte Chemie - International Edition, 47(37), 7082-7086.

50. Rishton, G. M. (2008). Molecular diversity in the context of leadlikeness: Compound properties that enable effective biochemical screening. Current Opinion in Chemical Biology, 12(3), 340-351.

<Cites Inglese, J., Johnson, R. et al. 2007>

51. Bayley, H., Cronin, B., Heron, A., Holden, M. A., Hwang, W. L., Syeda, R., et al. (2008). Droplet interface bilayers. Molecular BioSystems, 4(12), 1191-1208.

52. Sekhon, B. S. (2008). Chemical biology: Past, present and future. Current Chemical Biology, 2(3), 278-311.

53. Ljosa, V., & Carpenter, A. E. (2008). High-throughput screens for fluorescent dye discovery. Trends in Biotechnology, 26(10), 527-530.

54. Jonker, N., Kool, J., Krabbe, J. G., Retra, K., Lingeman, H., & Irth, H. (2008). Screening of protein-ligand interactions using dynamic protein-affinity chromatography solid-phase extraction-liquid chromatography-mass spectrometry. Journal of Chromatography A, 1205(1-2), 71-77. Sekhon, B. S. (2008). Chemical genetics-an overview. National Academy Science Letters, 31(5-6), 133-148.

55. Sharlow, E. R., Leimgruber, S., Yellow-Duke, A., Barrett, R., Wang, Q. J., & Lazo, J. S. (2008). Development, validation and implementation of immobilized metal affinity for phosphochemicals (IMAP)-based high-throughput screening assays for low-molecular-weight compound libraries. Nature Protocols, 3(8), 1350-1363.

56. Gregori-Puigjané, E., & Mestres, J. (2008). A ligand-based approach to mining the chemogenomic space of drugs. Combinatorial Chemistry and High Throughput Screening, 11(8), 669-676. Walser, M., Leibundgut, R. M., Pellaux, R., Panke, S., & Held, M. (2008). Isolation of monoclonal microcarriers colonized by fluorescent E. coli. Cytometry Part A, 73(9), 788-798.

57. Lundin, A., & Eriksson, J. (2008). A real-time bioluminescent HTS method for measuring protein kinase activity influenced neither by ATP concentration nor by luciferase inhibition. Assay and Drug Development Technologies, 6(4), 531-541.

58. Deiters, E., Song, B., Chauvin, A. -., Vandevyver, C. D. B., & Bünzli, J. -. G. (2008). Effect of the length of polyoxyethylene substituents on luminescent bimetallic lanthanide bioprobes. New Journal of Chemistry, 32(7), 1140-1152.

59. Pei, J., Dishinger, J. F., Roman, D. L., Rungwanitcha, C., Neubig, R. R., & Kennedy, R. T. (2008). Microfabricated channel array electrophoresis for characterization and screening of enzymes using RGS-G protein interactions as a model system. Analytical Chemistry, 80(13), 5225-5231.

60. Derler, I., Fritsch, R., Schindl, R., & Romanin, C. (2008). CRAC inhibitors: Identification and potential. Expert Opinion on Drug Discovery, 3(7), 787-800.

61. Hübel, K., Leßmann, T., & Waldmann, H. (2008). Chemical biology - identification of small molecule modulators of cellular activity by natural product inspired synthesis. Chemical Society Reviews, 37(7), 1361-1374.

62. Huebner, A., Olguin, L. F., Bratton, D., Whyte, G., Huck, W. T. S., De Mello, A. J., et al. (2008). Development of quantitative cell-based enzyme assays in microdroplets. Analytical Chemistry, 80(10), 3890-3896.

63. Engel, S., Skoumbourdis, A. P., Childress, J., Neumann, S., Deschamps, J. R., Thomas, C. J., et al. (2008). A virtual screen for diverse ligands: Discovery of selective G protein-coupled receptor antagonists. Journal of the American Chemical Society, 130(15), 5115-5123.

64. Young, D. B., Perkins, M. D., Duncan, K., & Barry III, C. E. (2008). Confronting the scientific obstacles to global control of tuberculosis. Journal of Clinical Investigation, 118(4), 1255-1265.

65. Arany, Z., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008). Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1α and oxidative phosphorylation. Proceedings of the National Academy of Sciences of the United States of America, 105(12), 4721-4726.

66. Gross, B. J., Swoboda, J. G., & Walker, S. (2008). A strategy to discover inhibitors of O-linked glycosylation. Journal of the American Chemical Society, 130(2), 440-441. Vogel, K. W., Zhong, Z., Bi, K., & Pollok, B. A. (2008). Developing assays for kinase drug discovery - where have the advances come from? Expert Opinion on Drug Discovery, 3(1), 115-129.

67. Jurica, M. S. (2008). Searching for a wrench to throw into the splicing machine. Nature Chemical Biology, 4(1), 3-6.

68. Carpenter, A. E. (2007). Image-based chemical screening. Nature Chemical Biology, 3(8), 461-465.

<Cites Inglese, J., Shamu, R. et al. 2007>

69. Ling, X. B. (2008). High throughput screening informatics. Combinatorial Chemistry and High Throughput Screening, 11(3), 249-257.

70. Osak, B., & Fitzgerald, L. R. (2007). A β-lactamase reporter assay for monitoring the activation of the smoothened pathway. Assay and Drug Development Technologies, 5(6), 785-792.

71. Peterson, R. T. (2008). Chemical biology and the limits of reductionism. Nature Chemical Biology, 4(11), 635-638.

72. Sekhon, B. S. (2008). Chemical biology: Past, present and future. Current Chemical Biology, 2(3), 278-311.

73. Krysan, D. J., & Didone, L. (2008). A high-throughput screening assay for small molecules that disrupt yeast cell integrity. Journal of Biomolecular Screening, 13(7), 657-664.

74. Muskavitch, M. A. T., Barteneva, N., & Gubbels, M. -. (2008). Chemogenomics and parasitology: Small molecules and cell-based assays to study infectious processes. Combinatorial Chemistry and High Throughput Screening, 11(8), 624-646.

<Cites Johnston. et al 2007>

75. Lescar, J., Luo, D., Xu, T., Sampath, A., Lim, S. P., Canard, B., et al. (2008). Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from dengue virus as a target. Antiviral Research, 80(2), 94-101.

76. Mueller, N. H., Pattabiraman, N., Ansarah-Sobrinho, C., Viswanathan, P., Pierson, T. C., & Padmanabhan, R. (2008). Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Antimicrobial Agents and Chemotherapy, 52(9), 3385-3393.

<Cites Lazo, J., Brady, L. et al 2007>

77. Camp, D., Avery, V., Street, I., & Quinn, R. J. (2007). Progress toward establishing an open access molecular screening capability in the australasian region. ACS Chemical Biology, 2(12), 764-767.

78. Huryn, D. M., & Cosford, N. D. P. (2007). Chapter 26 the molecular libraries screening center network (MLSCN): Identifying chemical probes of biological systems. Annual Reports in Medicinal Chemistry 42, 401-416.

79. McDonald, P. R., Roy, A., Tylor, B., Price, A., Sittampalam, S., Weir, S., et al. (2008). High throughput screening in academia - drug discovery initiatives at the university of kansas. Drug Discovery World, 9(4), 59-76.

80. Enna, S. J., Feuerstein, G. Z., Piette, J., & Williams, M. (2008). Fifty years of biochemical pharmacology: The discipline and the journal. Biochemical Pharmacology, 76(1), 1-10.

81. Madoux, F., Li, X., Chase, P., Zastrow, G., Cameron, M. D., Conkright, J. J., et al. (2008). Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening. Molecular Pharmacology, 73(6), 1776-1784.

82. Kumar, N., Afeyan, R., Kim, H. -., & Lauffenburger, D. A. (2008). Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Molecular Pharmacology, 73(6), 1668-1678.

83. Rosen, H., Gonzalez-Cabrera, P., Marsolais, D., Cahalan, S., Don, A. S., & Sanna, M. G. (2008). Modulating tone: The overture of S1P receptor immunotherapeutics. Immunological Reviews, 223(1), 221-235.

<Cites Lazo, J., Skoko, J.J. et al 2007>

84. Przyklenk, K., Maynard, M., Darling, C. E., & Whittaker, P. (2008). Aging mouse hearts are refractory to infarct size reduction with post-conditioning. Journal of the American College of Cardiology, 51(14), 1393-1398.

85. Yi, T., & Lindner, D. (2008). The role and target potential of protein tyrosine phosphatases in cancer. Current Oncology Reports, 10(2), 114-121.

<Cites Lee, H.-K. et al 2007>

86. Rees, S., & Wise, A. (2008). The industrialisation of cellular screening. Expert Opinion on Drug Discovery, 3(7), 715-723.

87. Snowden, M., & Green, D. V. S. (2008). The impact of diversity-based, high-throughput screening on drug discovery: “chance favours the prepared mind”. Current Opinion in Drug Discovery and Development, 11(4), 553-558.

<Cites Oprea, T. , Tropsha, A. et al. 2007>

88. Ling, X. B. (2008). High throughput screening informatics. Combinatorial Chemistry and High Throughput Screening, 11(3), 249-257.

89. Thiele, D. J., & Gitlin, J. D. (2008). Assembling the pieces. Nature Chemical Biology, 4(3), 145-147.

90. Lehár, J., Stockwell, B. R., Giaever, G., & Nislow, C. (2008). Combination chemical genetics. Nature Chemical Biology, 4(11), 674-681.

91. Sekhon, B. S. (2008). Chemical biology: Past, present and future. Current Chemical Biology, 2(3), 278-311.

92. Latino, D. A. R. S., Zhang, Q. -., & Aires-de-Sousa, J. (2008). Genome-scale classification of metabolic reactions and assignment of EC numbers with self-organizing maps. Bioinformatics, 24(19), 2236-2244.

<Cites Oprea, T., Allu, T.K., et al. 2007>

93. Guido, R. V. C., Oliva, G., & Andricopulo, A. D. (2008). Virtual screening and its integration with modern drug design technologies. Current Medicinal Chemistry, 15(1), 37-46.

94. Taylor, P., Blackburn, E., Sheng, Y. G., Harding, S., Hsin, K. -., Kan, D., et al. (2008). Ligand discovery and virtual screening using the program LIDAEUS. British Journal of Pharmacology, 153(SUPPL. 1), S55-S67.

95. Wallquist, A., Huang, R., & Covell, D. G. (2007). Chemoinformatic analysis of NCI preclinical tumor data: Evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors. Journal of Chemical Information and Modeling, 47(4), 1414-1427.

96. Waszkowycz, B. (2008). Towards improving compound selection in structure-based virtual screening. Drug Discovery Today, 13(5-6), 219-226.

97. Grabowski, K., Baringhaus, K. -., & Schneider, G. (2008). Scaffold diversity of natural products: Inspiration for combinatorial library design. Natural Product Reports, 25(5), 892-904.

98. Damm, K. L., Ung, P. M. U., Quintero, J. J., Gestwicki, J. E., & Carlson, H. A. (2008). A poke in the eye: Inhibiting HIV-1 protease through its flap-recognition pocket. Biopolymers, 89(8), 643-652.

99. Fattori, D., Squarcia, A., & Bartoli, S. (2008). Fragment-based approach to drug lead discovery: Overview and advances in various techniques. Drugs in R and D, 9(4), 217-227.

100. Fotouhi, N., Gillespie, P., & Goodnow Jr., R. (2008). Lead generation: Reality check on commonly held views. Expert Opinion on Drug Discovery, 3(7), 733-744.

101. Rishton, G. M. (2008). Molecular diversity in the context of leadlikeness: Compound properties that enable effective biochemical screening. Current Opinion in Chemical Biology, 12(3), 340-351.

102. Babaoglu, K., Simconov, A., Irwin, J. J., Nelson, M. E., Feng, B., Thomas, C. J., et al. (2008). Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase. Journal of Medicinal Chemistry, 51(8), 2502-2511.

103. Sun, H. (2008). Pharmacophore-based virtual screening. Current Medicinal Chemistry, 15(10), 1018-1024.

<Cites Prossnitz, E. et al. 2007>

104. Arias-Loza, P. A., Jazbutyte, V., & Pelzer, T. (2008). Genetic and pharmacologic strategies to determine the function of estrogen receptor α and estrogen receptor β in cardiovascular system. Gender Medicine, 5(SUPPL. 1), S34-S45.

105. Jordan, V. C., & O’Malley, B. W. (2007). Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. Journal of Clinical Oncology, 25(36), 5815-5824.

106. Lucas, T. F. G., Siu, E. R., Esteves, C. A., Monteiro, H. P., Oliveira, C. A., & Porto, C. S. et al. (2008). 17Beta-estradiol induces the translocation of the estrogen receptors ESR1 and ESR2 to the cell membrane, MAPK3/1 phosphorylation and proliferation of cultured immature rat sertoli cells. Biology of Reproduction, 78(1), 101-114.

107. Pietras, R. J., & Márquez-Garbán, D. C. (2007). Membrane-associated estrogen receptor signaling pathways in human cancers. Clinical Cancer Research, 13(16), 4672-4676.

108. Wang, C., Dehghani, B., Magrisso, I. J., Rick, E. A., Bonhomme, E., Cody, D. B., et al. (2008). GPR30 contributes to estrogen-induced thymic atrophy. Molecular Endocrinology, 22(3), 636-648.

109. Winzell, M. S., & Ahrén, B. (2007). G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacology and Therapeutics, 116(3), 437-448.

110. Carroll, S. M., Bridgham, J. T., & Thornton, J. W. (2008). Evolution of hormone signaling in elasmobranchs by exploitation of promiscuous receptors. Molecular Biology and Evolution, 25(12), 2643-2652.

111. Xu, S., Cheng, Y., Keast, J. R., & Osborne, P. B. (2008). 17β-estradiol activates estrogen receptor β-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons. Endocrinology, 149(11), 5540-5548.

112. Kamanga-Sollo, E., White, M. E., Chung, K. Y., Johnson, B. J., & Dayton, W. R. (2008). Potential role of G-protein-coupled receptor 30 (GPR30) in estradiol-17β-stimulated IGF-I mRNA expression in bovine satellite cell cultures. Domestic Animal Endocrinology, 35(3), 254-262.

113. Sahlin, L., Stjernholm-Vladic, Y., Roos, N., Masironi, B., & Ekman-Ordeberg, G. (2008). Impaired leukocyte influx in cervix of postterm women not responding to prostaglandin priming. Reproductive Biology and Endocrinology, 6

114. Luoma, J. I., Boulware, M. I., & Mermelstein, P. G. (2008). Caveolin proteins and estrogen signaling in the brain. Molecular and Cellular Endocrinology, 290(1-2), 8-13.

115. Kelly, M. J., & Rønnekleiv, O. K. (2008). Membrane-initiated estrogen signaling in hypothalamic neurons. Molecular and Cellular Endocrinology, 290(1-2), 14-23.

116. Kamanga-Sollo, E., White, M. E., Hathaway, M. R., Chung, K. Y., Johnson, B. J., & Dayton, W. R. (2008). Roles of IGF-I and the estrogen, androgen and IGF-I receptors in estradiol-17β- and trenbolone acetate-stimulated proliferation of cultured bovine satellite cells. Domestic Animal Endocrinology, 35(1), 88-97.

117. Montague, D., Weickert, C. S., Tomaskovic-Crook, E., Rothmond, D. A., Kleinman, J. E., & Rubinow, D. R. (2008). Oestrogen receptor α localisation in the prefrontal cortex of three mammalian species. Journal of Neuroendocrinology, 20(7), 893-903.

118. Mccarthy, M. M., Schwarz, J. M., Wright, C. L., & Dean, S. L. (2008). Mechanisms mediating oestradiol modulation of the developing brain. Journal of Neuroendocrinology, 20(6), 777-783.

119. Heino, T. J., Chagin, A. S., & Sävendahl, L. (2008). The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone. Journal of Endocrinology, 197(2), R1-R6.

120. de Kloet, E. R., Karst, H., & Joëls, M. (2008). Corticosteroid hormones in the central stress response: Quick-and-slow. Frontiers in Neuroendocrinology, 29(2), 268-272.

121. Ríos-Cardona, D., Ricardo-González, R. R., Chawla, A., & Ferrell Jr., J. E. (2008). A role for GPRx, a novel GPR3/6/12-related G-protein coupled receptor, in the maintenance of meiotic arrest in xenopus laevis oocytes. Developmental Biology, 317(1), 380-388.

122. Dudek, P., & Picard, D. (2008). Genomics of signaling crosstalk of estrogen receptor α in breast cancer cells. PLoS ONE, 3(3)

<Cites Revankar, C., et al. 2007>

123. Heino, T. J., Chagin, A. S., & Sävendahl, L. (2008). The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone. Journal of Endocrinology, 197(2), R1-R6.

124. Scott, P. -., Tremblay, A., Brochu, M., & St-Louis, J. (2007). Vasorelaxant action of 17β-estradiol in rat uterine arteries: Role of nitric oxide synthases and estrogen receptors. American Journal of Physiology - Heart and Circulatory Physiology, 293(6), H3713-H3719.

125. Xu, S., Cheng, Y., Keast, J. R., & Osborne, P. B. (2008). 17β-estradiol activates estrogen receptor β-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons. Endocrinology, 149(11), 5540-5548.

126. Albanito, L., Sisci, D., Aquila, S., Brunelli, E., Vivacqua, A., Madeo, A., et al. (2008). Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology, 149(8), 3799-3808.

127. Pang, Y., Dong, J., & Thomas, P. (2008). Estrogen signaling characteristics of atlantic croaker G protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology, 149(7), 3410-3426.

<Cites Rosen, et al. 2007>

128. Hinkovska-Galcheva, V., VanWay, S. M., Shanley, T. P., & Kunkel, R. G. (2008). The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis. Current Opinion in Investigational Drugs, 9(11), 1192-1205.

129. Matheu, M. P., Beeton, C., Garcia, A., Chi, V., Rangaraju, S., Safrina, O., et al. (2008). Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity, 29(4), 602-614.

130. Rivera, J., Proia, R. L., & Olivera, A. (2008). The alliance of sphingosine-1-phosphate and its receptors in immunity. Nature Reviews Immunology, 8(10), 753-

131. Schepers, K., Swart, E., Van Heijst, J. W. J., Gerlach, C., Castrucci, M., Sie, D., et al. (2008). Dissecting T cell lineage relationships by cellular barcoding. Journal of Experimental Medicine, 205(10), 2309-2318.

132. Hla, T., Venkataraman, K., & Michaud, J. (2008). The vascular S1P gradient-cellular sources and biological significance. Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids, 1781(9), 477-482.

133. Kono, M., Allende, M. L., & Proia, R. L. (2008). Sphingosine-1-phosphate regulation of mammalian development. Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids, 1781(9), 435-441.

134. Lynch, K. R., & Macdonald, T. L. (2008). Sphingosine 1-phosphate chemical biology. Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids, 1781(9), 508-512.

135. Takuwa, Y., Okamoto, Y., Yoshioka, K., & Takuwa, N. (2008). Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids, 1781(9), 483-488.

136. Khanna, K. M., & Lefrançois, L. (2008). Geography and plumbing control the T cell response to infection. Immunology and Cell Biology, 86(5), 416-422.

137. Jo, S. -., Bajwa, A., Awad, A. S., Lynch, K. R., & Okusa, M. D. (2008). Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease. Kidney International, 73(11), 1220-1230.

138. Hogquist, K. A., Weinreich, M. A., & Jameson, S. C. (2008). T-cell migration: Kruppeled T cells move again. Immunology and Cell Biology, 86(4), 297-298.

139. Takabe, K., Paugh, S. W., Milstien, S., & Spiegel, S. (2008). Inside-out signaling of sphingosine-1-phosphate: Therapeutic targets. Pharmacological Reviews, 60(2), 181-195.

140. Olivera, A. (2008). Unraveling the complexities of sphingosine-1-phosphate function: The mast cell model. Prostaglandins and Other Lipid Mediators, 86(1-4), 1-11.

141. Cahalan, M. D., & Parker, I. (2008). Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs

142. Horga, A., & Montalban, X. (2008). FTY720 (fingolimod) for relapsing multiple sclerosis. Expert Review of Neurotherapeutics, 8(5), 699-714.

143. Wymann, M. P., & Schneiter, R. (2008). Lipid signalling in disease. Nature Reviews Molecular Cell Biology, 9(2), 162-176.

144. Pham, T. H. M., Okada, T., Matloubian, M., Lo, C. G., & Cyster, J. G. (2008). S1P1 receptor signaling overrides retention mediated by gαi-coupled receptors to promote T cell egress. Immunity, 28(1), 122-133.

145. Cinamon, G., Zachariah, M. A., Lam, O. M., Foss Jr., F. W., & Cyster, J. G. (2008). Follicular shuttling of marginal zone B cells facilitates antigen transport. Nature Immunology, 9(1), 54-62. Schwab, S. R., & Cyster, J. G. (2007). Finding a way out: Lymphocyte egress from lymphoid organs. Nature Immunology, 8(12), 1295-1301.

146. Walzer, T., Chiossone, L., Chaix, J., Calver, A., Carozzo, C., Garrigue-Antar, L., et al. (2007). Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunology, 8(12), 1337-1344.

147. Cooke, N., & Zécri, F. (2007). Chapter 16 sphingosine 1-phosphate type 1 receptor modulators: Recent advances and therapeutic potential

148. Pabst, R. (2007). Plasticity and heterogeneity of lymphoid organs. what are the criteria to call a lymphoid organ primary, secondary or tertiary? Immunology Letters, 112(1), 1-8.

149. Oskeritzian, C. A., Milstien, S., & Spiegel, S. (2007). Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis. Pharmacology and Therapeutics, 115(3), 390-399.

150. Chun, J. (2007). Immunology: The sources of a lipid conundrum. Science, 316(5822), 208-210.

<Cites Simons,P.C., et al. 2007>

151. Nagy, P., & Szollosi, J. (2008). Seeing through protein complexes by high-throughput FRET. Cytometry Part A, 73(5), 388-389.

152. Szöllosi, J., & Vereb, G. (2008). From molecular interactions to tissue organization - diversity of evolving cytometric approaches from a hungarian perspective. Cytometry Part A, 73(3), 182-185.

<Cites Sklar, L., et al. 2007>

153. Kenakin, T., & Domanico, P. (2007). Pharmacologists get a bigger and better tool box. Current Opinion in Pharmacology, 7(5), 505-506.

154. Walser, M., Leibundgut, R. M., Pellaux, R., Panke, S., & Held, M. (2008). Isolation of monoclonal microcarriers colonized by fluorescent E. coli. Cytometry Part A, 73(9), 788-798.

155. Enna, S. J., Feuerstein, G. Z., Piette, J., & Williams, M. (2008). Fifty years of biochemical pharmacology: The discipline and the journal. Biochemical Pharmacology, 76(1), 1-10.

156. Tárnok, A. (2008). A focus on high-content cytometry. Cytometry Part A, 73(5), 381-383.

<Cites Sun, A., et al. 2007>

157. Yoon, J. -., Chawla, D., Paal, T., Ndungu, M., Du, Y., Kurtkaya, S., et al. (2008). High-throughput screening-based identification of paramyxovirus inhibitors. Journal of Biomolecular Screening, 13(7), 591-608.

158. Sun, A., Yoon, J. -., Yin, Y., Prussia, A., Yang, Y., Min, J., et al. (2008). Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex. Journal of Medicinal Chemistry, 51(13), 3731-3741.

<Cites Thepchatri, P., et al. 2007>

159. Okamoto, I., Yamasaki, R., Sawamura, M., Kato, T., Nagayama, N., & Takeya, T. et al. (2007). Redox-induced conformational alteration of N,N-diarylamides. Organic Letters, 9(26), 5545-5547.

160. Onodera, H., Kaneko, M., Takahashi, Y., Uochi, Y., Funahashi, J., Nakashima, T., et al. (2008). Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity. Bioorganic and Medicinal Chemistry Letters, 18(5), 1588-1591.

161. Onuoha, S. C., Mukund, S. R., Coulstock, E. T., Sengerovà, B., Shaw, J., & McLaughlin, S. H. et al. (2007). Mechanistic studies on Hsp90 inhibition by ansamycin derivatives. Journal of Molecular Biology, 372(2), 287-297.

162. Young, J., & Taylor, R. E. (2008). Evolution of polyketides: Post-PKS processing in the formation of spiroketals. Natural Product Reports, 25(4), 651-655.

163. Erdélyi, M., Pfeiffer, B., Hauenstein, K., Fohrer, J., Gertsch, J., Altmann, K. -., et al. (2008). Conformational preferences of natural and C3-modified epothilones in aqueous solution. Journal of Medicinal Chemistry, 51(5), 1469-1473.

<Cites Tran. et al. 2007>

164. Manning, H. C., Lander, A., McKinley, E., & Mutic, N. J. (2008). Accelerating the development of novel molecular imaging probes: A role for high-throughput screening. Journal of Nuclear Medicine, 49(9), 1401-1404.

165. Chico, T. J. A., Ingham, P. W., & Crossman, D. C. (2008). Modeling cardiovascular disease in the zebrafish. Trends in Cardiovascular Medicine, 18(4), 150-155.

166. Crawford, A. D., Esguerra, C. V., & De Witte, P. A. M. (2008). Fishing for drugs from nature: Zebrafish as a technology platform for natural product discovery. Planta Medica, 74(6), 624-632.

167. Eimon, P. (2008). Disease modelling and toxicity screening in transgenic zebrafish embryos. Bio Tech International, 20(2), 12-15.

<Cites Wu, Y., Campos, S., et al. 2007>

168. Tholouli, E., Sweeney, E., Barrow, E., Clay, V., Hoyland, J. A., & Byers, R. J. (2008). Quantum dots light up pathology. Journal of Pathology, 216(3), 275-285.

169. Lawrence, W. G., Varadi, G., Entine, G., Podniesinski, E., & Wallace, P. K. (2008). Enhanced red and near infrared detection in flow cytometry using avalanche photodiodes. Cytometry Part A, 73(8), 767-776.

<Cites Wu, Y., Lopez,G., et al. 2007>

170. Zhang, C. -., & Johnson, L. W. (2008). Simple and accurate quantification of quantum dots via single-particle counting. Journal of the American Chemical Society, 130(12), 3750-3751.

171. Lawrence, W. G., Varadi, G., Entine, G., Podniesinski, E., & Wallace, P. K. (2008). Enhanced red and near infrared detection in flow cytometry using avalanche photodiodes. Cytometry Part A, 73(8), 767-776.

<Cites Zheng, et al. 2007>

172. Kozarich, J. W. (2007). New LSD therapies unfolding. Chemistry and Biology, 14(9), 976-977.

173. Mu, T. -., Fowler, D. M., & Kelly, J. W. (2008). Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis. PLoS Biology, 6(2), 0253-0265.

174. Wei, H., Kim, S. -., Zhang, Z., Tsai, P. -., Wisniewski, K. R., & Mukherjee, A. B. (2008). ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Human Molecular Genetics, 17(4), 469-477.

175. Sekhon, B. S. (2008). Chemical biology: Past, present and future. Current Chemical Biology, 2(3), 278-311.

176. Kruer, M. C., & Steiner, R. D. (2008). The role of evidence-based medicine and clinical trials in rare genetic disorders. Clinical Genetics, 74(3), 197-207.

177. Wasserstein, M. P., & McGovern, M. M. (2008). Genetic basis of the lipid storage disorders. Future Lipidology, 3(2), 189-201.

178. Enns, G. M., & Huhn, S. L. (2008). Central nervous system therapy for lysosomal storage disorders. Neurosurgical Focus, 24(3-4)

179. Sauer, T., Patel, M., Chan, C. -., & Tuo, J. (2008). Unfolding the therapeutic potential of chemical chaperones for age-related macular degeneration. Expert Review of Ophthalmology, 3(1), 29-42.